cancer risk assessment
A Good Physician Treats The Disease; A Great Physician Helps The Patient To Prevent It.
How many times have your patients expressed concern about a personal or family history of cancer in their immediate or extended family.
Most likely, they are concerned that they may have an increased risk for developing the same type of cancers but are unsure what do next and what course of preventative action they can take?
BACMAC has partnered with a leading company in personalized medicine, GeneID, and is proud to introduce PREVENTEST, the first Comprehensive Cancer Risk Assessment test designed to determine your patient’s risk of developing up to eight cancer types.
This non-invasive test helps the patient and clinician determine the level of risk for some of the most common solid tumor cancers including Breast, Ovarian, Endometrial, Pancreas, Prostate, Skin, Stomach and ColoRectal Cancers.
PREVENTEST™ can help determine your patient’s level of risk, of developing one or more of these 8 prevalent cancers.
The future is truly now when it comes to personalized risk assessment.
Expertise & Impact
Simplicity
• Automates variant analysis bioinformatics pipeline
• Connects detected variants to public annotations allowing faster assessment
Scalability
• Scalable from a few to thousands of samples
• Scalable from genes to genomes
Speed
• Optimized for semiconductor sequencing for faster and more accurate results
• Configurable modules accelerate free workflow development
Reports
Advancing clinical research break bioinformatics barriers with automated variant analysis. GeneID introduces the GeneID Reporter, a streamlined, cloud-hosted suite of tools that automates analysis, annotation, reporting, and archiving of semiconductor sequencing data generated on Ion PGM™ or Ion Proton™ Sequencers. Designed to perform routine sequencing assays, helps to quickly identify and easily interpret DNA variants.
The Technology
The software comprises a suite of bioinformatics tools that streamline and simplify analysis, annotation, and archiving of Ion semiconductor sequencing data. Designed specifically for researchers performing routine sequencing assays, the GeneID Reporter Software helps to overcome the bioinformatics barriers and interpret DNA variants faster and more consistently making our testing process "unique."
How many times have your patients expressed concern about a personal or family history of cancer in their immediate or extended family.
Most likely, they are concerned that they may have an increased risk for developing the same type of cancers but are unsure what do next and what course of preventative action they can take?
BACMAC has partnered with a leading company in personalized medicine, GeneID, and is proud to introduce PREVENTEST, the first Comprehensive Cancer Risk Assessment test designed to determine your patient’s risk of developing up to eight cancer types.
This non-invasive test helps the patient and clinician determine the level of risk for some of the most common solid tumor cancers including Breast, Ovarian, Endometrial, Pancreas, Prostate, Skin, Stomach and ColoRectal Cancers.
PREVENTEST™ can help determine your patient’s level of risk, of developing one or more of these 8 prevalent cancers.
The future is truly now when it comes to personalized risk assessment.
Expertise & Impact
Simplicity
• Automates variant analysis bioinformatics pipeline
• Connects detected variants to public annotations allowing faster assessment
Scalability
• Scalable from a few to thousands of samples
• Scalable from genes to genomes
Speed
• Optimized for semiconductor sequencing for faster and more accurate results
• Configurable modules accelerate free workflow development
Reports
Advancing clinical research break bioinformatics barriers with automated variant analysis. GeneID introduces the GeneID Reporter, a streamlined, cloud-hosted suite of tools that automates analysis, annotation, reporting, and archiving of semiconductor sequencing data generated on Ion PGM™ or Ion Proton™ Sequencers. Designed to perform routine sequencing assays, helps to quickly identify and easily interpret DNA variants.
The Technology
The software comprises a suite of bioinformatics tools that streamline and simplify analysis, annotation, and archiving of Ion semiconductor sequencing data. Designed specifically for researchers performing routine sequencing assays, the GeneID Reporter Software helps to overcome the bioinformatics barriers and interpret DNA variants faster and more consistently making our testing process "unique."
To learn more, please call 800.240.9473 today.
